Canada
Psychedelics firm Numinus says amendments made to the country's Special Access Programme come into effect in January
Hi, what are you looking for?
Mugglehead Investment Magazine
Psychedelics
Business
The psychedelics firm has been aggressively expanding lab space while pushing ahead with clinical trials
Business
The new facility will feature the firm's ketamine-assisted therapy program, as well as a range of health and lifestyle services
Business
The methods will be available as part of third-party client services
Psychedelics
Some are criticizing researcher Stamets for trying to capitalize on the phenomenon of 'stacking,' where psychedelics are paired with health supplements
Cannabis
Cannabis and 'classical' psychedelics could act on similar receptors
International
Conservative MP and drug policy reform chair Crispin Blunt suggests reclassifying the substance to a less severe category of the country's drug law
Health and Safety
It’s the first federal grant to be awarded for psychedelic treatment research in 50 years
Canada
When asked why patient requests for legal psilocybin are being denied or delayed, the agency said studies are the best route for access
Canada
TheraPsil's CEO expects change for psilocybin to come in a matter of months because of the work done for cannabis
